Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
Ahmed M Saeed, Tarek Tawfeek AboulNasrOphthalmology Department, Benha University, Egypt Purpose: To provide a feasible solution to the problem of failed glaucoma surgery. The aim was to evaluate the efficacy and safety of the additional effects of a combined surgical approach. This approach augment...
Guardado en:
Autores principales: | Saeed AM, AboulNasr TT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4136707ea7e1490782c0a3724a820463 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour MR, et al.
Publicado: (2011) -
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
por: Mostafaei A
Publicado: (2011) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey HM, et al.
Publicado: (2011) -
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
por: Freiberg FJ, et al.
Publicado: (2013) -
Risk factors for choroidal detachment after trabeculectomy with mitomycin C
por: Haga A, et al.
Publicado: (2013)